Analysts Mixed on 3M as Consumer Strain, PFAS Risks Linger

3M MMM.N topped Wall Street estimates for Q1 profit as cost-control measures ‌helped offset inflationary and tariff-linked pressures, even as the industrial giant warned of a $125 million jump in annual costs due to soaring oil prices

Median price target of 20 brokerages covering the stock is $171; average rating is "buy" - data compiled by LSEG

BURDEN OF PROOF ON ORGANIC GROWTH

Wolfe Research ("outperform," PT: $182) says "a little skeptical given the frayed U.S. consumer, but still see path towards the high end on EPS"

Jefferies ("hold," PT: $170) says while end-market conditions remain uncertain, innovation initiatives appear to be gaining traction and may contribute 1.6%-1.9% to sales in 2027 and 1.8%-2.2% in 2028

RBC Capital Markets ("underperform," PT: $133) says operational excellence metrics continue to improve along with a new product pipeline

The looming multi-billion-dollar per- and polyfluoroalkyl substances (PFAS) liability remains a longer-term overhang - RBC

Morgan Stanley ("equal-weight," PT: $165) says debate will be whether the guided organic acceleration is achievable